Clinical trials: Coxarthrosis; Secondary
Osteoarthritis, Hip, Coxarthrosis; Primary
Osseointegration of THA Grafted by PolyNASS (ACTISURF-CERAFIT® ) Versus Non-grafted THA (CERAFIT®)
The infection rate after Total Hip Arthroplasty (THA) is about 1%. It is a serious condition, with high morbidity, sometimes fatal, requiring costly treatment.
- Conditions
- Osteoarthritis, Hip, Coxarthrosis; Primary, Coxarthrosis; Secondary, Osteonecrosis; Aseptic, Idiopathic
- Trial name
- NCT03113981
- Testing
- Total Hip Arthroplasty
- Where
- 7 sites in France
- Volunteers
- 340 people
- Sponsor
- Societe ACTIVBIOMAT
Primary and Secondary Coxarthrosis, Dysplasia Coxarthrosis
Assessment of Implant Fixation and SF-36 for Short Hip-Stems - A Prospective Clinical Study
The primary purpose of this study was to evaluate the implant fixation of the NANOS™ Neck Preserving Hip Stem (OHST Medizintechnik AG, distributed by Smith \& Nephew GmbH, Marl, Germany) by measuring the migration of the implant…
- Conditions
- Primary and Secondary Coxarthrosis, Dysplasia Coxarthrosis, Post-traumatic Necrosis of the Femoral Head
- Trial name
- NCT04172129
- Testing
- Total Hip Arthroplasty
- Where
- Germany
- Volunteers
- 60 people
- Sponsor
- Smith & Nephew Orthopaedics AG